HighTower Advisors
CORV

HighTower Advisors’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

HighTower Advisors’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-10,000
Closed -$4K – 2607
2019
Q4 		$4K Buy
+10,000
New +$16.6K ﹤0.01% 2236

Other funds holding CORV

BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $764M AUM 24.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

HighTower Advisors's CORV Position: Q1 2020 in Review

HighTower Advisors sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q1 2020, closing a stake of 10,000 shares — an estimated $4K sold.

HighTower Advisors first reported a position in CORV in Q4 2019 and held it in 1 quarter. The position peaked at $4K in Q4 2019. 27 funds tracked by Wall St. Rank hold CORV as of Q1 2020.

  • HighTower Advisors reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q1 2020 after selling out during the quarter.
  • HighTower Advisors sold 10,000 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q1 2020, an estimated $4K.
  • HighTower Advisors first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q4 2019 and held it in 1 quarter.
  • HighTower Advisors's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $4K in Q4 2019.
  • 27 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q1 2020.

Based on HighTower Advisors's 13F filing for Q1 2020, filed 21 May 2020.